bevacizumab
pharmaceutical drug
Details
- chemical formula
- C₆₆₃₈H₁₀₁₆₀N₁₇₂₀O₂₁₀₈S₄₄
- mass
- 149000
- medical condition treated
- rare urinary tract tumor, retinal vein occlusion, islet cell carcinoma, non-small-cell lung carcinoma, eye disease, metastatic melanoma, neuroendocrine carcinoma, colon adenocarcinoma, secondary neoplasm, peritoneum cancer, brain cancer, colon cancer
- World Health Organisation international non-proprietary name
- bevacizumab
Nothing in the MetaHistoryBook collection references this item yet.